Amorepacific Ventures

Kim Yun-kyoung leads the day-to-day investment operations as Head of Amorepacific Ventures, operating from both Seoul and San Francisco. Ultimate investment authority rests with Chairman Suh Kyung-bae, who controls the Amorepacific Group and serves as the firm's sole LP through the family’s corporate holdings.

The firm pursues a direct-only strategy, writing equity and co-investment checks into Seed and Series A companies. There is no public record of the vehicle participating in LP commitments to external venture capital or private equity funds.

The firm concentrates on beauty and personal-care technology, digital health, artificial intelligence, and enterprise software with consumer-facing applications. Its strategic thesis focuses on innovations that can eventually integrate into Amorepacific's broader K-beauty ecosystem, including personalized skin diagnostics, genomic skincare, and next-generation e-commerce tools.

Deployment concentrates on South Korea and the United States, with the firm maintaining offices in both Seoul and San Francisco. A smaller allocation targets select opportunities in Southeast Asia, leveraging the parent group's established commercial presence in markets like Thailand and Vietnam.

The firm actively co-invests alongside established US and Korean venture capital funds through direct equity stakes and special-purpose vehicles. This collaborative approach pairs external financial validation with the strategic benefit of Amorepacific's corporate resources, making the vehicle an attractive syndicate partner for early-stage beauty-tech rounds.